Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Dexdor----4件: 2, 4, 6, 70 💬
2Dexmedetomidine
(Dexdor)
1件: Dexmedetomidine2件: Dexmedetomidine (Dexdor),
Dexmedetomidine hydrochloride 💬
3件: ADRA2A,
ADRA2B,
ADRA2C 💬
4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬15件: 2, 4, 6, 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
3Dexmedetomidine 1
(Dexdor)
1件: Dexmedetomidine2件: Dexmedetomidine (Dexdor),
Dexmedetomidine hydrochloride 💬
3件: ADRA2A,
ADRA2B,
ADRA2C 💬
4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 280 💬
4Dexmedetomidine 2
(Dexdor)
1件: Dexmedetomidine2件: Dexmedetomidine (Dexdor),
Dexmedetomidine hydrochloride 💬
3件: ADRA2A,
ADRA2B,
ADRA2C 💬
4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 280 💬
5Dexmedetomidine 3
(Dexdor)
1件: Dexmedetomidine2件: Dexmedetomidine (Dexdor),
Dexmedetomidine hydrochloride 💬
3件: ADRA2A,
ADRA2B,
ADRA2C 💬
4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 280 💬
6Dexmedetomidine group
(Dexdor)
1件: Dexmedetomidine2件: Dexmedetomidine (Dexdor),
Dexmedetomidine hydrochloride 💬
3件: ADRA2A,
ADRA2B,
ADRA2C 💬
4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 70 💬
7Dexmedetomidine Hcl 100 Mcg/mL Inj
(Dexdor)
1件: Dexmedetomidine2件: Dexmedetomidine (Dexdor),
Dexmedetomidine hydrochloride 💬
3件: ADRA2A,
ADRA2B,
ADRA2C 💬
4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 215 💬
8DEXMEDETOMIDINE HYDROCHLORIDE
(Dexdor)
1件: Dexmedetomidine2件: Dexmedetomidine (Dexdor),
Dexmedetomidine hydrochloride 💬
3件: ADRA2A,
ADRA2B,
ADRA2C 💬
4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 70 💬
9Dexmedetomidine Hydrochloride Infusion
(Dexdor)
1件: Dexmedetomidine2件: Dexmedetomidine (Dexdor),
Dexmedetomidine hydrochloride 💬
3件: ADRA2A,
ADRA2B,
ADRA2C 💬
4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 6 💬
10Dexmedetomidine injection
(Dexdor)
1件: Dexmedetomidine2件: Dexmedetomidine (Dexdor),
Dexmedetomidine hydrochloride 💬
3件: ADRA2A,
ADRA2B,
ADRA2C 💬
4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 70 💬
11Dexmedetomidine with ropivacaine
(Dexdor)
2件: Dexmedetomidine,
Ropivacaine
4件: Dexmedetomidine (Dexdor),
Dexmedetomidine hydrochloride ,
Ropivacaine hydrochloride ,
Ropivacaine 💬
9件: ADRA2A,
ADRA2B,
ADRA2C,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬
9件: Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, Hormone signaling, IgSF CAM signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cGMP-PKG signaling pathway 💬1件: 70 💬
12DexmedetomidineProduct Name: DexdorPharmaceutical Form: Concentrate and solvent for solution for infusionINN or Proposed INN: DEXMEDETOMIDINECAS Number: 113775-47-6Pharmaceutical form of the placebo: Concentrate and solvent for solution for infusionRoute of administration of the placebo: Intravenous use----1件: 70 💬
13Fentanyl (Low Dose) + Dexmedetomidine
(Dexdor)
2件: Dexmedetomidine,
Fentanyl
5件: Fentanyl ,
Dexmedetomidine (Dexdor),
Dexmedetomidine hydrochloride ,
Fentanyl citrate ,
Fentanyl hydrochloride 💬
4件: ADRA2A,
ADRA2B,
ADRA2C,
OPRM1 💬
6件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 215 💬
14Scopolamine, atropine, edaravone and dexmedetomidine
(Dexdor)
4件: Atropine,
Dexmedetomidine,
Edaravone,
Scopolamine
7件: Atropine ,
Scopolamine ,
Dexmedetomidine (Dexdor),
Dexmedetomidine hydrochloride ,
Edaravone ,
Atropine sulfate ,
Scopolamine hydrobromide 💬
8件: ADRA2A,
ADRA2B,
ADRA2C,
CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬
16件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Hormone signaling, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 2 💬